Neurocrine Biosciences
NBIX · NASDAQ
Bulios Fair Price
$145.71
0.4% downside
Trenutna cena
$146.23
Po podatkih Bulios Fair Price se delnica NBIX trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Neurocrine Biosciences, Inc. is an American biotechnology company headquartered in San Francisco, California. The company focuses on the development of drugs for the treatment of neurological and endocrine disorders. Their main products include medications for the treatment of sleep disorders, movement disorders, and endocrine disorders such as diabetes. Neurocrine Biosciences specializes in research and development of new drug formulations targeting specific biological targets related to neurological and endocrine diseases. The company is known for its innovative drugs and technologies that help patients with these serious conditions. Shares of Neurocrine Biosciences, Inc. are publicly traded on the NASDAQ stock exchange.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Kyle W. Gano
Employees
2,500
Headquarters
San Diego
Prihajajoči dogodki
Earnings
Upcoming earnings report